Compound Evidence File
#EC-2026-0239
Stanozolol (Winstrol) Raw
Filed under Raw Materials. The bureau holds 100 laboratory returns for this compound from 32 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
32 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 10 Nov 2025 | 23 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 10.0 | 10.0 | 8 Mar 2026 | 8 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Feb 2026 | 6 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 28 May 2026 | 9 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 10.0 | 10.0 | 5 Mar 2026 | 8 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 24 Jan 2026 | 11 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 19 Dec 2025 | 28 May 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 8 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Mar 2026 | 12 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Nov 2025 | 15 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 9.9 | 8 May 2026 | 21 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Feb 2026 | 23 May 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Jan 2026 | 9 Mar 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 | 27 Feb 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 9.1 | 9.1 | 9.1 | 8 Jul 2025 | 8 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.9 | 7.8 | 10.0 | 21 May 2026 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.4 | 6.1 | 9.4 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.4 | 7.9 | 8.8 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.0 | 6.5 | 9.3 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.0 | 7.1 | 9.7 | 23 May 2026 | 23 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 8.0 | 8.0 | 8.0 | 16 Mar 2025 | 16 Mar 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 4 | 7.3 | 6.5 | 8.8 | 14 Jan 2025 | 17 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 9 | 7.1 | 4.5 | 8.7 | 3 Jul 2025 | 23 May 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 7.1 | 7.1 | 7.1 | 11 Jun 2025 | 11 Jun 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 3 | 6.4 | 5.1 | 7.8 | 2 Apr 2025 | 20 May 2026 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 | 28 Mar 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 5.9 | 5.9 | 5.9 | 16 Mar 2025 | 16 Mar 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 3.3 | 3.3 | 3.3 | 8 Jul 2025 | 8 Jul 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for Stanozolol (Winstrol) Raw alone.